Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 401341 - 401360 out of 563611 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Norway | (C10AX09) ezetimibe (adm: O) | Ezetrol 10 mg | 30 stk, Blisterpakning, Tablett, 10 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
n/a | OrifarmAS |
| Norway | (C10AX09) ezetimibe (adm: O) | Ezetrol 10 mg | 98 stk, Blisterpakning, Tablett, 10 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
n/a | OrifarmAS |
| Norway | (C10AX13) evolocumab (adm: P) | Repatha 140 mg/ml | 2 x 1 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 140 mg/ml , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Dyslipidemias;Hypercholesterolemia | AmgenEuropeB.V. |
| Norway | (C10AX13) evolocumab (adm: P) | Repatha 140 mg/ml | 3 x 2 x 1 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 140 mg/ml , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Dyslipidemias;Hypercholesterolemia | AmgenEuropeB.V. |
| Norway | (C10AX13) evolocumab (adm: P) | Repatha 140 mg/ml | 1 ml, Ferdigfylt sprøyte, Injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 140 mg/ml , Ferdigfylt sprøyte | Retail price with vat |
$0-0 |
$0-0 |
Dyslipidemias;Hypercholesterolemia | AmgenEuropeB.V. |
| Norway | (C10AX13) evolocumab (adm: P) | Repatha 140 mg/ml | 1 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 140 mg/ml , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Dyslipidemias;Hypercholesterolemia | AmgenEuropeB.V. |
| Norway | (C10AX14) alirocumab (adm: P) | Praluent 150 mg/ml | 2 x 1 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 150 mg/ml , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Dyslipidemias | SanofiWinthropIndustrie |
| Norway | (C10AX14) alirocumab (adm: P) | Praluent 150 mg/ml | 2 x 3 x 1 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 150 mg/ml , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Dyslipidemias | SanofiWinthropIndustrie |
| Norway | (C10AX14) alirocumab (adm: P) | Praluent 150 mg/ml | 1 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 150 mg/ml , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Dyslipidemias | SanofiWinthropIndustrie |
| Norway | (C10AX14) alirocumab (adm: P) | Praluent 150 mg/ml | 6 x 1 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 150 mg/ml , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Dyslipidemias | SanofiWinthropIndustrie |
| Norway | (C10AX14) alirocumab (adm: P) | Praluent 150 mg/ml | 2 x 1 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 150 mg/ml , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Dyslipidemias | SanofiWinthropIndustrie |
| Norway | (C10AX14) alirocumab (adm: P) | Praluent 300 mg | 3 x 2 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 300 mg , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Dyslipidemias | SanofiWinthropIndustrie |
| Norway | (C10AX14) alirocumab (adm: P) | Praluent 300 mg | 3 x 2 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 300 mg , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Dyslipidemias | SanofiWinthropIndustrie |
| Norway | (C10AX14) alirocumab (adm: P) | Praluent 75 mg/ml | 2 x 1 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 75 mg/ml , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Dyslipidemias | SanofiWinthropIndustrie |
| Norway | (C10AX14) alirocumab (adm: P) | Praluent 75 mg/ml | 2 x 3 x 1 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 75 mg/ml , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Dyslipidemias | SanofiWinthropIndustrie |
| Norway | (C10AX14) alirocumab (adm: P) | Praluent 75 mg/ml | 1 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 75 mg/ml , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Dyslipidemias | SanofiWinthropIndustrie |
| Norway | (C10AX14) alirocumab (adm: P) | Praluent 75 mg/ml | 6 x 1 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 75 mg/ml , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Dyslipidemias | SanofiWinthropIndustrie |
| Norway | (C10AX14) alirocumab (adm: P) | Praluent 75 mg/ml | 2 x 1 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 75 mg/ml , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Dyslipidemias | SanofiWinthropIndustrie |
| Norway | (C10BA06) rosuvastatin and ezetimibe | Rosuvastatin/Ezetimib Krka 10 mg/10 mg | 90 stk, Blisterpakning, Tablett, filmdrasjert, 10 mg/10 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
n/a | KRKA,d.d.NovoMesto |
| Norway | (C10BA06) rosuvastatin and ezetimibe | Rosuvastatin/Ezetimib Krka 20 mg/10 mg | 90 stk, Blisterpakning, Tablett, filmdrasjert, 20 mg/10 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
n/a | KRKA,d.d.NovoMesto |
Pages
